Goldman Sachs’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.64M | Sell |
|
|||||
|
2025
Q1 | $5.25M | Buy |
|
|||||
|
2024
Q4 | $2.62M | Buy |
|
|||||
|
2024
Q3 | $2.42M | Buy |
|
|||||
|
2024
Q2 | $1.59M | Sell |
|
|||||
|
2024
Q1 | $6.72M | Buy |
|
|||||
|
2023
Q4 | $4.16M | Sell |
|
|||||
|
2023
Q3 | $7.04M | Sell |
|
|||||
|
2023
Q2 | $7.51M | Sell |
|
|||||
|
2023
Q1 | $13M | Buy |
|
|||||
|
2022
Q4 | $10.9M | Buy |
|
|||||
|
2022
Q3 | $5.47M | Buy |
|
|||||
|
2022
Q2 | $2.19M | Sell |
|
|||||
|
2022
Q1 | $23M | Sell |
|
|||||
|
2021
Q4 | $26.6M | Sell |
|
|||||
|
2021
Q3 | $29.7M | Buy |
|
|||||
|
2021
Q2 | $23.1M | Sell |
|
|||||
|
2021
Q1 | $32.9M | Buy |
|
|||||
|
2020
Q4 | $32.5M | Buy |
|
|||||
|
2020
Q3 | $22M | Sell |
|
|||||
|
2020
Q2 | $25.9M | Sell |
|
|||||
|
2020
Q1 | $22.3M | Sell |
|
|||||
|
2019
Q4 | $39.5M | Buy |
|
|||||
|
2019
Q3 | $30.4M | Buy |
|
|||||
|
2019
Q2 | $27.2M | Sell |
|
|||||
|
2019
Q1 | $29.4M | Sell |
|
|||||
|
2018
Q4 | $28.3M | Buy |
|
|||||
|
2018
Q3 | $22.6M | Sell |
|
|||||
|
2018
Q2 | $22.1M | Sell |
|
|||||
|
2018
Q1 | $21.6M | Buy |
|
|||||
|
2017
Q4 | $22.4M | Sell |
|
|||||
|
2017
Q3 | $39.4M | Buy |
|
|||||
|
2017
Q2 | $39.1M | Buy |
|
|||||
|
2017
Q1 | $32.9M | Buy |
|
|||||
|
2016
Q4 | $20.2M | Sell |
|
|||||
|
2016
Q3 | $32.2M | Buy |
|
|||||
|
2016
Q2 | $25.9M | Sell |
|
|||||
|
2016
Q1 | $104M | Buy |
|
|||||
|
2015
Q4 | $57.3M | Buy |
|
|||||
|
2015
Q3 | $28.8M | Buy |
|
|||||
|
2015
Q2 | $29.9M | Buy |
|
|||||
|
2015
Q1 | $501K | Sell |
|
|||||
|
2014
Q4 | $16.7M | Buy |
|
|||||
|
2014
Q3 | $16.4M | Sell |
|
|||||
|
2014
Q2 | $52.1M | Buy |
|
|||||
|
2014
Q1 | $16.9M | Buy |
|
|||||
|
2013
Q4 | $1.08M | Buy |
|
|||||
|
2013
Q3 | $677K | Buy |
|